Study shows durable benefits of early HIV treatment

By Gene Emery (Reuters Health) – Early treatment of the human immunodeficiency virus (HIV) can dramatically reduce the odds of passing the deadly disease on to others, and the protection persists for years, according to final results from a major study that looked at the timing of antiretroviral therapy, or ART. The findings were presented at the International AIDS Conference in Durban, South Africa and published online by the New England Journal of Medicine. Early therapy for HIV, the virus that causes AIDS, “was associated with a 93% lower risk of linked partner infection than was delayed ART,” reported the team, led by Dr. Myron Cohen at the University of North Carolina at Chapel Hill.
Sexual Health News Headlines – Yahoo! News